Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS - MarketWatch (press release)

Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS
MarketWatch (press release)
Several factors including a patient's antiretroviral drug regimen and the HIV virus itself are thought to contribute to HIV-associated lipodystrophy, ...

and more »

continue reading

Theratechnologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ... - PR-inside.com (press release)

Theratechnologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ...
PR-inside.com (press release)
Tesamorelin is its lead product that completed its phase III clinical trails for treating HIV-associated lipodystrophy and is undergoing phase II clinical ...

and more »

continue reading

HIV associated with poorer sexual function for women - Aidsmap

HIV associated with poorer sexual function for women
Aidsmap
For women with HIV, increasing age and a lower CD4 cell count were associated with lower sexual functioning. “Our analysis reveals that the burden of sexual ...

and more »

continue reading